- Presentations
- 2
- Markets
- 1
Entyvio is a brand of Vedolizumab marketed by Takeda Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Vedolizumab
- Brand owner
- Takeda Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 108 mg/0.68 mL injection, 300 mg/5 mL powder for injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Entyvio 108 mg/0.68 mL injectionSubcutaneous Cold chain | Takeda Pharmaceuticals | US FDA | Available on request |
| Entyvio 300 mg/5 mL powder for injectionIntravenous Cold chain | Takeda Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Vedolizumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Entyvio
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.